npj Precision Oncology

Article	Citations
An automated deep learning pipeline for EMVI classification and response prediction of rectal cancer using baseline MRI: a multi-centre study	263
The dynamic immune behavior of primary and metastatic ovarian carcinoma	128
Exosome- transported FER inhibitor suppresses progression of diffuse large B-cell lymphoma via regulating AJUBA/Hippo axis	118
Sub-regional radiomics combining multichannel 2-dimensional or 3-dimensional deep learning for predicting neoadjuvant chemo-immunotherapy response in esophageal squamous cell carcinoma: a multicenter	111
Improved prediction of MAPKi response duration in melanoma patients using genomic data and machine learning	108
Multi-modal characterization of metabolic and immune gene clusters in adrenocortical carcinoma treatment	105
Complement activation in tumor microenvironment after neoadjuvant therapy and its impact on pancreatic cancer outcomes	103
Co-targeting KRAS G12C and EGFR reduces both mutant and wild-type RAS-GTP	98
Development and testing of a polygenic risk score for breast cancer aggressiveness	97
Mucin-1: a promising pan-cancer therapeutic target	81
Constitutional mismatch repair deficiency mimicking Lynch syndrome is associated with hypomorphic mismatch repair gene variants	68
A perspective on life-cycle health technology assessment and real-world evidence for precision oncology in Canada	66
Analyses of canine cancer mutations and treatment outcomes using real-world clinico-genomics data of 2119 dogs	61
A protein-encoding CCDC7 circular RNA inhibits the progression of prostate cancer by up-regulating FLRT3	61
Barriers and opportunities in pancreatic cancer immunotherapy	60
BRAF v600E–mutant cancers treated with vemurafenib alone or in combination with everolimus, sorafenib, or crizotinib or with paclitaxel and carboplatin (VEM-PLUS) study	58
Tumor break load quantitates structural variant-associated genomic instability with biological and clinical relevance across cancers	56
Imaging and AI based chromatin biomarkers for diagnosis and therapy evaluation from liquid biopsies	55
Genome-wide analyses reveals an association between invasive urothelial carcinoma in the Shetland sheepdog and NIPAL1	54
Developing survival prediction models in colorectal cancer using epigenome-wide DNA methylation data from whole blood	53
Patient-level proteomic network prediction by explainable artificial intelligence	52
Author Correction: An automated deep learning pipeline for EMVI classification and response prediction of rectal cancer using baseline MRI: a multi-centre study	51
Grading of lung adenocarcinomas with simultaneous segmentation by artificial intelligence (GLASS-AI)	50
Circulating tumor DNA in ALK-positive anaplastic large cell lymphoma: a proof-of-concept study	50
Assessment of TROP2, CEACAM5 and DLL3 in metastatic prostate cancer: Expression landscape and molecular correlates	49

PD-1 blockade potentiates neoadjuvant chemotherapy in NSCLC via increasing CD127+ and KLRG1+ CD8 T cells	49
Interferon signaling and ferroptosis in tumor immunology and therapy	49
An international multi-institutional validation study of the algorithm for prostate cancer detection and Gleason grading	48
Erigoster B targeting DECR1 induces ferroptosis of breast cancer cells via promoting phosphatidylcholine/arachidonic acid metabolism	46
m6A reader IGF2BP2-stabilized lncRNA LHX1-DT inhibits renal cell carcinoma (RCC) cell proliferation and invasion by sponging miR-590-5p	45
Relationship among DDR gene mutations, TMB and PD-L1 in solid tumour genomes identified using clinically actionable biomarker assays	45
Multiregional transcriptomic profiling provides improved prognostic insight in localized non-small cell lung cancer	43
A universal immunohistochemistry analyzer for generalizing AI-driven assessment of immunohistochemistry across immunostains and cancer types	42
User-centered design approach to visualize PROMs for molecular tumor boards	42
Baseline biomarkers of efficacy and on-treatment immune-profile changes associated with bempegaldesleukin plus nivolumab	42
Stage-dependent spatial distribution and prognostic value of CD8+ tissue-resident memory T cells in NSCLC	42
Single-cell landscape of bronchoalveolar immune cells in patients with immune checkpoint inhibitor-related pneumonitis	41
Genomic and transcriptomic analyses identify distinctive features of triple-negative inflammatory breast cancer	41
Enhanced efficacy of ipilimumab plus nivolumab in angiogenic subtypes of metastatic clear-cell renal cell carcinoma	40
Real-world experience of Molecular Tumour Boards for clinical decision-making for cancer patients	39
Targeting Nrf2/PHKG2 axis to enhance radiosensitivity in NSCLC	39
Establishing predictive machine learning models for drug responses in patient derived cell culture	39
Histological transformation to gliosarcoma with combined BRAF/MEK inhibition in BRAF V600E mutated glioblastoma	39
ECM-based molecular subtypes define prognostic, EMT status, and therapeutic diversity in IDH-mutant gliomas	38
Collagen disorder architecture features are associated with clinical, molecular, genetic factors and survival outcomes in colon cancer	37
Multi-omics machine learning to study host-microbiome interactions in early-onset colorectal cancer	36
Self-supervised attention-based deep learning for pan-cancer mutation prediction from histopathology	36
TRIM65 regulates glucose metabolic reprogramming to promote glioma cell proliferation via ubiquitination and degradation of AMPK	35
Machine learning model for predicting tertiary lymphoid structures and treatment response in triple-negative breast cancer	34
First-in-human prospective trial of sonobiopsy in high-grade glioma patients using neuronavigation-guided focused ultrasound	34
Discovery of prognostic lncRNAs in colorectal cancer using spatial transcriptomics	34
Pan-cancer molecular tumor board experience with biomarker-driven precision immunotherapy	34
Compound heterozygous MSH3 germline variants and associated tumor somatic DNA mismatch repair dysfunction	33
Deciphering associations between three RNA splicing-related genetic variants and lung cancer risk	33
Author Correction: Imaging and AI based chromatin biomarkers for diagnosis and therapy evaluation from liquid biopsies	33
Progress in personalized immunotherapy for patients with brain metastasis	32
Tumor fraction-based prognostic tool for cancer patients referred to early phase clinical trials	30
A core driver gene set identified based on geMER reveals its potential driver mechanism in pan-cancer	30
ML-based sequential analysis to assist selection between VMP and RD for newly diagnosed multiple myeloma	30
Enhancing adoptive cell therapy: future strategies for immune cell radioprotection in neuro-oncology	30
Novel molecular subtypes of METex14 non-small cell lung cancer with distinct biological and clinical significance	30
Mediator kinase inhibition impedes transcriptional plasticity and prevents resistance to ERK/MAPK-targeted therapy in KRAS-mutant cancers	29
The SMARCA4R1157W mutation facilitates chromatin remodeling and confers PRMT1/SMARCA4 inhibitors sensitivity in colorectal cancer	29
In-depth inference of transcriptional regulatory networks reveals NPM1 as a therapeutic ribosomal regulator in MYC-amplified medulloblastoma	29
HER3 targeting augments the efficacy of panobinostat in claudin-low triple-negative breast cancer cells	28
Prediction of homologous recombination deficiency identifies colorectal tumors sensitive to PARP inhibition	28
Leveraging patient derived models of FGFR2 fusion positive intrahepatic cholangiocarcinoma to identify synergistic therapies	28
AI-driven eyelid tumor classification in ocular oncology using proteomic data	28
Machine learning algorithms for predicting glioma patient prognosis based on CD163+FPR3+ macrophage signature	27
Selpercatinib combination with the mitochondria-targeted antioxidant MitoQ effectively suppresses RET–mutant thyroid cancer	27
A complex phylogeny of lineage plasticity in metastatic castration resistant prostate cancer	27
CNTNAP4 signaling regulates osteosarcoma disease progression	26
An analysis of research biopsy core variability from over 5000 prospectively collected core samples	26
Deep learning-based quantification of eosinophils and lymphocytes shows complementary prognostic effects in colorectal cancer patients	26
Colorectal cancer risk stratification on histological slides based on survival curves predicted by deep learning	26

Perfusion-based ex vivo culture of frozen ovarian cancer tissues with preserved tumor microenvironment	26
Augmented reality microscopy to bridge trust between AI and pathologists	26
MDM2 inhibition is associated with the emergence of TP53-altered clonal hematopoiesis	26
Predicting ROS1 and ALK fusions in NSCLC from H&E slides with a two-step vision transformer approach	25
A patient-designed tissue-engineered model of the infiltrative glioblastoma microenvironment	25
Artificial intelligence-based assessment of PD-L1 expression in diffuse large B cell lymphoma	25
Role of large language models in the multidisciplinary decision-making process for patients with renal cell carcinoma: a pilot experience	25
A multimodal fusion system predicting survival benefits of immune checkpoint inhibitors in unresectable hepatocellular carcinoma	25
Unlocking the potential of TIGIT in enhancing therapeutic strategies for acute myeloid leukemia through combined azacitidine therapy	24
A multi-cancer early detection blood test using machine learning detects early-stage cancers lacking USPSTF-recommended screening	24
Cancer-related cells and oncosomes in the liquid biopsy of pancreatic cancer patients undergoing surgery	24
Plasma proteomic biomarkers predict therapeutic responses in advanced biliary tract cancer patients receiving Camrelizumab plus the GEMOX treatment	24
Homologous recombination deficiency signatures in gastrointestinal and thoracic cancers correlate with platinum therapy duration	24
ChemoID-guided therapy improves objective response rate in recurrent platinum-resistant ovarian cancer randomized clinical trial	23
Activation of CD44/PAK1/AKT signaling promotes resistance to FGFR1 inhibition in squamous-cell lung cancer	23
Artificial intelligence-based epigenomic, transcriptomic and histologic signatures of tobacco use in oral squamous cell carcinoma	23
Potential of pre-diagnostic metabolomics for colorectal cancer risk assessment or early detection	23
Efficacy of PARP inhibitor therapy after targeted BRAF/MEK failure in advanced melanoma	23
Personalized prediction of anticancer potential of non-oncology drugs through learning from genome derived molecular pathways	22
Multi-output prediction of dose–response curves enables drug repositioning and biomarker discovery	22
PUM1-TRAF3 fusion protein activates non-canonical NF-κB signaling via rescued NIK in biliary tract cancer	22
ALK fusions in the pan-cancer setting: another tumor-agnostic target?	22
Complete morphologic response to gilteritinib in ALK-rearranged acute myeloid leukemia	22
Chemokine expression predicts T cell-inflammation and improved survival with checkpoint inhibition across solid cancers	21
Germline pathogenic variants in DNA repair pathways: a key feature in a significant subset of translocation-associated sarcomas	21
Genetic and oncogenic features of RASGRF fusions	21
Potential utility of risk stratification for multicancer screening with liquid biopsy tests	21
Transcriptional profiling clarifies a program of enzalutamide extreme non-response in lethal prostate cancer	21
Clock pathway inhibitor overcomes tumor immune-exclusion via regulation of fibrocyte differentiation	21
High TGF-β signature predicts immunotherapy resistance in gynecologic cancer patients treated with immune checkpoint inhibition	21
Development and interpretation of a multimodal predictive model for prognosis of gastrointestinal stromal tumor	21
Multicenter radio-multiomic analysis for predicting breast cancer outcome and unravelling imaging-biological connection	21
ARHGAP4/MYH9/β-catenin/c-Jun positive feedback loop promotes colorectal cancer stemness	20
Personalized circulating tumor DNA dynamics inform survival and response to immune checkpoint blockade in recurrent/metastatic head and neck cancer	20
APOE-high myeloid cells are uniquely associated with metastatic intrathoracic lymph nodes obtained by EBUS-TBNA in primary lung cancer	20
LINE1 insertion into the NACC2 locus disrupts the HDM2 axis and activates lung oncogenic signaling	20
Striking efficacy of a vaccine targeting TOP2A for triple-negative breast cancer immunoprevention	20
Functional cure with single agent olutasidenib in relapsed IDH1/NPM1 co-mutated AML	19
Use of PSMA PET/CT to detect prostate cancer metastatic to a preexisting thyroid nodule	19
Integrative analysis of KEAP1/NFE2L2 alterations across 3600+ tumors reveals an NRF2 expression signature as a prognostic biomarker in cancer	19
Ligand-receptor interactions combined with histopathology for improved prognostic modeling in HPV-negative head and neck squamous cell carcinoma	19
Author Correction: A targetable OSGIN1–AMPK–SLC2A3 axis controls the vulnerability of ovarian cancer to ferroptosis	19
NCT/DKFZ MASTER handbook of interpreting whole-genome, transcriptome, and methylome data for precision oncology	19
Whole-genome analysis of an aggressive metastatic pancreatic solid pseudopapillary neoplasm	19
The drug efficacy testing in 3D cultures platform identifies effective drugs for ovarian cancer patients	19
Novel paediatric case of a spinal high-grade astrocytoma with piloid features in a patient with Noonan Syndrome	19
Tertiary lymphoid structures potentially promote immune checkpoint inhibitor response in SMARCB1-deficient medullary renal cell carcinoma	18
Evaluating cell culture reliability in pediatric brain tumor primary cells through DNA methylation profiling	18
Complete response to fifth-line anti-PD-1 rechallenge in fumarate hydratase-mutated papillary renal cell carcinoma	18
GD2: hopes and challenges for the treatment of pediatric patients with tumors of the central nervous system	18
Design of self-assembled micelles based on natural dual-targeting strategies and evaluation of their anti-liver cancer effects as drug delivery systems	18
Exceptional response to the ATR inhibitor, camonsertib, in a patient with ALT+ metastatic melanoma	18
Imaging immunity in patients with cancer using positron emission tomography	18
Predicting survival in prospective clinical trials using weakly-supervised QSP	18
Multi-omics analyses reveal interactions between GREM1+ fibroblasts and SPP1+ macrophages in gastric cancer	17
Real life outcome analysis of breast cancer brain metastases treated with Trastuzumab Deruxtecan	17
Author Correction: Predicting the tumor microenvironment composition and immunotherapy response in non-small cell lung cancer from digital histopathology images	17
Impact of TP53 mutations in Triple Negative Breast Cancer	17
HDAC6 facilitates LUAD progression by inducing EMT and enhancing macrophage polarization towards the M2 phenotype	17
Tackling FGFR3-driven bladder cancer with a promising synergistic FGFR/HDAC targeted therapy	17
Progress and challenges of artificial intelligence in lung cancer clinical translation	17
Machine learning-driven multi-targeted drug discovery in colon cancer using biomarker signatures	17
Opportunities and challenges for patient-derived models of brain tumors in functional precision medicine	17
A review of machine learning methods for cancer characterization from microbiome data	17
Element-specific estimation of background mutation rates in whole cancer genomes through transfer learning	16
Precision immuno-oncology approach for four malignant tumors in siblings with constitutional mismatch repair deficiency syndrome	16
Prediction and analysis of tumor infiltrating lymphocytes across 28 cancers by TILScout using deep learning	16
Comprehensive genetic profiling and molecularly guided treatment for patients with primary CNS tumors	16
Development of potent antibody drug conjugates against ICAM1+ cancer cells in preclinical models of cholangiocarcinoma	16
A comprehensive analysis of minimally differentially methylated regions common to pediatric and adult solid tumors	16
Multi-omics analysis deciphers intercellular communication regulating oxidative stress to promote oral squamous cell carcinoma progression	16
Deep learning-based detection and semi-quantitative model for spread through air spaces (STAS) in lung adenocarcinoma	16
A destabilizing Y891D mutation in activated EGFR impairs sensitivity to kinase inhibition	15
Plasma epigenomic profiling reveals treatment-emergent squamous transformation in prostate cancer	15
A phase II trial of mTORC1/2 inhibition in STK11 deficient non small cell lung cancer	15
Integrative molecular analyses define correlates of high B7-H3 expression in metastatic castrate-resistant prostate cancer	15
Spatial tumor immune microenvironment phenotypes in ovarian cancer	15
Secrets of DNA-PKcs beyond DNA repair	15
DNA methylation at quantitative trait loci (mQTLs) varies with cell type and nonheritable factors and may improve breast cancer risk assessment	15
Pre-radiotherapy ctDNA liquid biopsy for risk stratification of oligometastatic non-small cell lung cancer	15

Single-cell transcriptome sequencing reveals spatial distribution of IL34+ cancer-associated fibroblasts in hepatocellular carcinoma tumor microenvironment	15
Towards precision radiation oncology: endocrine therapy response as a biomarker for personalization of breast radiotherapy	15
Integrative whole slide image and spatial transcriptomics analysis with QuST and QuPath	15
An appraisal of genetic testing for prostate cancer susceptibility	15
Single-cell transcriptome analysis identifies MIF as a novel tumor-associated neutrophil marker for pancreatic ductal adenocarcinoma	15
Multi-omics analysis reveals NNMT as a master metabolic regulator of metastasis in esophageal squamous cell carcinoma	15
Biallelic EPCAM deletions induce tissue-specific DNA repair deficiency and cancer predisposition	14
Integrating histopathology and transcriptomics for spatial tumor microenvironment profiling in a melanoma case study	14
HAPIR: a refined Hallmark gene set-based machine learning approach for predicting immunotherapy response in cancer patients	14
Identification of novel prognostic and predictive biomarkers in salivary duct carcinoma via comprehensive molecular profiling	14
Single-cell analysis of gastric pre-cancerous and cancer lesions reveals cell lineage diversity and intratumoral heterogeneity	14
Fast, accurate, and racially unbiased pan-cancer tumor-only variant calling with tabular machine learning	14
Integration of pre-treatment computational radiomics, deep radiomics, and transcriptomics enhances soft-tissue sarcoma patient prognosis	14
Upregulation of POLE and proficient DNA repair are features of CIC::DUX4 sarcomas	14
Single-cell spatial architectures associated with clinical outcome in head and neck squamous cell carcinoma	14
Defining the extracellular matrix for targeted immunotherapy in adult and pediatric brain cancer	14
Methylation cytometric pretreatment blood immune profiles with tumor mutation burden as prognostic indicators for survival outcomes in head and neck cancer patients on anti-PD-1 therapy	14
Author Correction: Naltriben promotes tumor growth by activating the TRPM7-mediated development of the anti-inflammatory M2 phenotype	14
Multimodal spatial proteomic profiling in acute myeloid leukemia	14
All models are wrong and yours are useless: making clinical prediction models impactful for patients	13
High risk clear cell renal cell carcinoma microenvironments contain protumour immunophenotypes lacking specific immune checkpoints	13
Comprehensive analysis of targetable mutations and tumor microenvironment in urachal cancer	13
Proteogenomic analysis of enriched HGSOC tumor epithelium identifies prognostic signatures and therapeutic vulnerabilities	13
Author Correction: An interpretable machine learning system for colorectal cancer diagnosis from pathology slides	13
Trans-ancestry transcriptome-wide association and functional studies to uncover novel susceptibility genes and therapeutic targets for colorectal cancer	13
Emerging innovations in theranostics for pancreatic neuroendocrine tumors	13
A morphometric signature to identify ductal carcinoma in situ with a low risk of progression	13
A multiparameter liquid biopsy approach allows to track melanoma dynamics and identify early treatment resistance	13
Cell graph neural networks enable the precise prediction of patient survival in gastric cancer	13
Complete response to alectinib in ALK-fusion metastatic salivary ductal carcinoma	13
Collision of germline POLE and PMS2 variants in a young patient treated with immune checkpoint inhibitors	13
Survival-inferred fragility of statistical significance in phase III oncology trials	13
Genomic landscape of liquid biopsy mutations in TP53 and DNA damage genes in cancer patients	13
Revealing neuroendocrine transformation in gynecological cancers through genomic analysis	13
Latent class analysis-derived classification improves the cancer-specific death stratification of molecular subtyping in colorectal cancer	13
Accurate prediction of disease-free and overall survival in non-small cell lung cancer using patient-level multimodal weakly supervised learning	13
Adaptive Darwinian off-target resistance mechanisms to selective RET inhibition in RET driven cancer	12
Molecular characterization of low-grade serous ovarian carcinoma identifies genomic aberrations according to hormone receptor expression	12
MC1R signaling through the cAMP-CREB/ATF-1 and ERK-NFκB pathways accelerates G1/S transition promoting breast cancer progression	12
Proximity of immune and tumor cells underlies response to BRAF/MEK-targeted therapies in metastatic melanoma patients	12
Diagnostic and prognostic potential of cell-free RNAs in cerebrospinal fluid and plasma for brain tumors	12
FOXA1-dependent NSUN2 facilitates the advancement of prostate cancer by preserving TRIM28 mRNA stability in a m5C-dependent manner	12
Prediction of early-stage melanoma recurrence using clinical and histopathologic features	12
Development of a deep learning model for cancer diagnosis by inspecting cell-free DNA end-motifs	12
Locoregional tumor burden and risk of mortality in metastatic breast cancer	12
Illuminating the future of precision cancer surgery with fluorescence imaging and artificial intelligence convergence	12
Pharmacogenomic discovery of genetically targeted cancer therapies optimized against clinical outcomes	12
Biopsy image-based deep learning for predicting pathologic response to neoadjuvant chemotherapy in patients with NSCLC	12
A single-cell based precision medicine approach using glioblastoma patient-specific models	12
Bayesian risk prediction model for colorectal cancer mortality through integration of clinicopathologic and genomic data	12
Challenges and opportunities associated with the MD Anderson IMPACT2 randomized study in precision oncology	12
Neoadjuvant therapy-induced immune dynamics and myeloid-associated resistance in advanced head and neck cancer	12
Immunologic correlates in a CIC::DUX4 fusion-positive sarcoma responsive to dual immune checkpoint blockade	12
Applying a multi-task and multi-instance framework to predict axillary lymph node metastases in breast cancer	12
A multi-modal deep learning model for prediction of Ki-67 for meningiomas using pretreatment MR images	12
Sotorasib resistance in KRAS G12C-mutant invasive mucinous adenocarcinoma with implications for VEGF-A	11
Deep learning predicts patients outcome and mutations from digitized histology slides in gastrointestinal stromal tumor	11
Role of GPX3+ astrocytes in breast cancer brain metastasis activated by circulating tumor cell exosomes	11
A deep learning model, NAFNet, predicts adverse pathology and recurrence in prostate cancer using MRIs	11
Comprehensive analysis of angiogenesis pattern and related immune landscape for individual treatment in osteosarcoma	11
Molecular landscape of ERBB2 alterations in 3000 advanced NSCLC patients	11
Multi-omics analysis unveils immunosuppressive microenvironment in the occurrence and development of multiple pulmonary lung cancers	11
ALDH1A1 promotes PARP inhibitor resistance by enhancing retinoic acid receptor-mediated DNA polymerase θ expression	11
G0S2: a potential target for NSCLC identified through prognostic models from multi-Omic analysis of regulatory T cell metabolic genes	11
Refined high-content imaging-based phenotypic drug screening in zebrafish xenografts	11
Intraoperative margin assessment for basal cell carcinoma with deep learning and histologic tumor mapping to surgical site	11
Identification of breast cancer subtypes and drug response prediction through forward and reverse translation	11
RNF4 mediated degradation of PDHA1 promotes colorectal cancer metabolism and metastasis	11
Multimodal analysis suggests differential immuno-metabolic crosstalk in lung squamous cell carcinoma and adenocarcinoma	11
Integrated drug resistance and leukemic stemness gene-expression scores predict outcomes in large cohort of over 3500 AML patients from 10 trials	11
Addressing racial and ethnic disparities in AACR project GENIE	10
Extreme wrinkling of the nuclear lamina is a morphological marker of cancer	10
A breast cancer classification and immune landscape analysis based on cancer stem-cell-related risk panel	10
MatchMiner: an open-source platform for cancer precision medicine	10
Super multiple primary lung cancers harbor high-frequency BRAF and low-frequency EGFR mutations in the MAPK pathway	10
Tumor-associated macrophage-related strategies for glioma immunotherapy	10
Unraveling the power of radiomics: prediction and exploration of lymph node metastasis in stage T1/2 esophageal squamous cell carcinoma	10
Development and validation of machine learning models for young-onset colorectal cancer risk stratification	10
A promptable CT foundation model for solid tumor evaluation	10
Vertical pathway inhibition of receptor tyrosine kinases and BAD with synergistic efficacy in triple negative breast cancer	10
Integrative bioinformatics analysis and experimental validation identify CHEK1 as an unfavorable prognostic biomarker related to immunosuppressive phenotypes in soft tissue sarcomas	10
Naltriben promotes tumor growth by activating the TRPM7-mediated development of the anti-inflammatory M2 phenotype	10
INHBA(+) cancer-associated fibroblasts generate an immunosuppressive tumor microenvironment in ovarian cancer	10
Impact of KRAS mutations and co-mutations on clinical outcomes in pancreatic ductal adenocarcinoma	10
Cell graph analysis in hepatocellular carcinoma: predicting local recurrence and identifying spatial relationship biomarkers	10
TKI type switching overcomes ROS1 L2086F in ROS1 fusion-positive cancers	10
Pathologic complete response to KEYNOTE522 and HER2-directed therapy for synchronous TNBC and HER2+ breast cancer	10
Survival improvement for patients with metastatic colorectal cancer over twenty years	10
Crizotinib in patients with tumors harboring ALK or ROS1 rearrangements in the NCI-MATCH trial	10
Anti-EGFR aptamer exhibits direct anti-cancer effects in NSCLC cells harboring EGFR L858R mutations	10
Induction immune-checkpoint inhibitors for resectable oncogene-mutant NSCLC: A multicenter pooled analysis	10
Multi-cancer detection of circulating tumor cells by targeting oncofetal chondroitin sulfate	10
Sequencing of cerebrospinal fluid cell-free DNA facilitated early differential diagnosis of intramedullary spinal cord tumors	10
Clonal dynamics and Stereo-seq resolve origin and phenotypic plasticity of adenosquamous carcinoma	10
A multidimensional atlas of human glioblastoma-like organoids reveals highly coordinated molecular networks and effective drugs	10